Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study

OBJECTIVE: To assess the efficacy/safety of tofacitinib in adult patients with active ankylosing spondylitis (AS). METHODS: This phase III, randomised, double-blind, placebo-controlled study enrolled patients aged ≥18 years diagnosed with active AS, meeting the modified New York criteria, with centr...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ann Rheum Dis
Egile Nagusiak: Deodhar, Atul, Sliwinska-Stanczyk, Paula, Xu, Huji, Baraliakos, Xenofon, Gensler, Lianne S, Fleishaker, Dona, Wang, Lisy, Wu, Joseph, Menon, Sujatha, Wang, Cunshan, Dina, Oluwaseyi, Fallon, Lara, Kanik, Keith S, van der Heijde, Désirée
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2021
Gaiak:
Spondyloarthritis
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8292568/
https://ncbi.nlm.nih.gov/pubmed/33906853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2020-219601
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak